News and Blogs

NSWRHP-BG-Gradient-255px.png
Be the first person to recommend this.
Dr Christine O'Neill, head of general surgery at Newcastle’s John Hunter Hospital and VMO General and Endocrine Surgeon specialising in treating thyroid cancer, is committed to enhancing patient autonomy and optimising psychosocial care outcomes for thyroid cancer patients. In Australia, thyroid cancer ranks as the ninth most common cancer, with approximately 4000 new diagnoses every year. The issue of 'overdiagnosis’ – where the cancer found would be unlikely to have produced symptoms or led to serious outcomes if undiscovered - is also significant. Frequently, thyroid cancer is detected incidentally in patients who are having scans for unrelated reasons, ...
0 comments
Be the first person to recommend this.
The purpose of the NSW Regional Cancer Research Network's Clinician Research Fellowship scheme is to build translational cancer research by increasing research capacity and capability across the geographical area covered by the Central Coast , Hunter New England , Mid-North Coast and Northern NSW Local Health District boundaries. This scheme is aimed at supporting regional clinical staff to undertake translational cancer research within their own institution and to contribute to the wider goals of the Network. Funding Support Available The Clinician Research Fellowship award is a maximum of $100,000 ...
0 comments
Be the first person to recommend this.
The NSW Regional Cancer Research Network’s Research Starter Grants are designed to grow research capacity and capabilities within the Network’s footprint by supporting new and emerging researchers , including medical and health professionals, to undertake translational cancer research projects. Is this scheme for you? 'Emerging researchers' (including health and medical professionals who have recently commenced their research careers) who are working in the geographical area covered by the Central Coast , Hunter New England , Mid-North Coast and Northern NSW Local Health Districts are ...
0 comments
Be the first person to recommend this.
Dr Jennifer Mackney, Clinical Specialist Physiotherapist (Perioperative medicine), respiratory scientist and honorary lecturer at the University of Newcastle, is based at John Hunter Hospital in Newcastle, New South Wales. Dr Mackney is the lead for prehabilitation services in the Hunter New England Local Health District (HNELHD) and is part of a clinical team that has advocated for and developed the exercise testing service to identify risk and facilitate optimisation for people preparing for major, high-risk surgeries in hospital. Dr Mackney's research and clinical work has demonstrated that ‘prehabilitation’ – improving a patient’s function capability ...
0 comments
Be the first person to recommend this.
The NSW Regional Cancer Network will soon be calling for Applications for Research Starter Grants | Applications opening 1 February 2024 Important Notice: This scheme does not open for applications until February 2024 therefore scheme documents are subject to minor change up to 31 January 2024 . Any modifications will be communicated through our online platform prior to the scheme opening date. Overview The NSW Regional Cancer Research Network will be opening the Research Starter Grants scheme in February ...
0 comments
Be the first person to recommend this.
Professor Hubert Hondermarck’ s research is positioned at the frontier between oncology and neuroscience, exploring the neural regulation of cancer. For the last two decades, Professor Hondermarck’s research has increased our understanding of the complex relationship between the nervous system and tumour development and survival. "It's an emerging area in research called Cancer Neuroscience” Professor Hondermarck explains “Our laboratory is contributing to this. It means looking at the role of the nerves and nervous system in the initiation and progression of cancer. This is something which has been underestimated up until now." By using cutting-edge ...
0 comments
Be the first person to recommend this.
Alison Hofman highly values patient-reported measures (PRMs) for enhancing psychosocial support for patients with cancer. With over two decades experience in oncology, emergency, and intensive care nursing, and as a dedicated Cancer Care Coordinator at Tamworth Hospital, Alison recognises the challenges and opportunities facing the implementation of PRMs in regional and remote areas. This has been further highlighted for Alison while undertaking her master's in advanced nursing. It’s this knowledge and practice gap that inspired Alison to seek new and innovative methods to utilise PRMs, aiming to improve healthcare professionals' insight into patient experiences ...
0 comments
Be the first person to recommend this.
Professor Joerg Lehmann and his team are working towards a more precise and harm-limiting method of radiation delivery for breast cancer patients. ‘Radiotherapy is an effective treatment for breast cancer both in the early stages and in palliation for locally advanced disease’ says Professor Lehmann, a Principal Medical Physics Specialist at Calvary Mater Newcastle and Conjoint Professor at the University of Newcastle , ‘However, while radiation plays a crucial role in treating breast cancer, research indicates that incidental exposure to the heart and lungs during treatment may lead to potential long-term risk’. Professor Lehmann is the ...
0 comments
Be the first person to recommend this.
The NSW Regional Cancer Research Network (NSWRCRN) is seeking Expressions of Interest for a Senior Research Partner (0.4FTE). This professional staff role will be central to building and maintaining a strong clinical cancer research program in collaboration with our Network Members located within the areas covered by our Network Footprint . The Senior Research Partner will work closely with the NSWRCRN Chief Investigator, Network Team, and large network of stakeholders to assist in the development of major and minor translational and clinical cancer research projects and research capacity building initiatives to ensure the Network’s research impact. ...
0 comments
Be the first person to recommend this.
The NSW Regional Cancer Research Networkis pleased to announce the successful recipients of the 2023 Clinician Research Fellowships. These fellowships aim to build translational cancer research capacity and capability, and will support clinical staff located at regional sites to undertake impactful research within their health services. The Clinician Research Fellowship scheme, funded through a Translational Cancer Research Capacity Building Grant from the Cancer Institute NSW, seeks to increase research capacity and capability across northern NSW – in the areas included in the Central Coast, Hunter New England, Mid-North Coast, and Northern NSW Local Health ...
0 comments
Be the first person to recommend this.
The NSW Regional Cancer Research Network is delighted to announce the successful recipients of the 2023 Shovel Ready' Translational Research Projects. These projects will make a significant contribution to improving cancer care across northern NSW - in the Central Coast, Hunter New England, Mid-North Coast, and Northern NSW Local Health District regions. These grants provide up to $50,000 per year for up to three years for projects in development or ready for testing in the real-world setting. The selected projects align with the Network's aim to: Improve cancer outcomes in NSW regional communities, with a particular focus on achieving ...
0 comments
Be the first person to recommend this.
SEEKING EXPRESSIONS OF INTEREST - SENIOR RESEARCH PARTNERs (2 POSITIONS) The NSW Regional Cancer Research Network (NSWRCRN) is seeking Expressions of Interest for two (2) Senior Research Partners. These professional staff roles will be central to building and maintaining a strong clinical cancer research program in collaboration with our Network Members. The Senior Research Partners will work closely with the NSWRCRN Chief Investigator, Network Team, and large network of stakeholders to assist in the development of major and minor translational and clinical cancer research projects and research capacity building initiatives to ensure the ...
0 comments
Be the first person to recommend this.
JOIN US IN SYDNEY! The three largest cancer research networks in NSW are working together to deliver the NSW Cancer Conference. Maridulu Budyari Gumal - SPHERE, in conjunction with Sydney Cancer Partners and NSW Regional Health Partners, are pleased to host the face-to-face NSW Cancer Conference on the 18 th & 19 th of September 2023 at the International Conference Centre (ICC) Sydney. The conference in its second year, represents a significant milestone for cancer research in NSW by bringing together both metropolitan and regional centres from across NSW for a truly state-wide, cross-institutional meeting focused on cancer research. The event will ...
0 comments
Be the first person to recommend this.
The NSW Regional Cancer Research Network is now calling for Expressions of Interest (EOIs) for ‘Shovel-Ready’ translational research projects. “Shovel-ready” refers to projects that are ready to commence or are in the late-stages of development and can commence in a short timeframe. EOI applications that align with the priorities of the NSW Regional Cancer Research Network and meet the eligibility criteria will be invited provide further detail on the proposed project for assessment. The ‘Shovel Ready’ NSW Regional Cancer Research Grants scheme will provide funding support of up to $50,000 p.a. for up to 3 years.. Projects must be ready to commence ...
0 comments
Be the first person to recommend this.
About the PHD Project This project aims to validate a blood-based early detection test for ovarian cancer. Early detection of ovarian cancer might significantly improve the overall survival rate of women with ovarian cancer due to the effective treatment of early-stage disease. Ovarian cancer is usually diagnosed at advanced stages with poor survival and limited treatment options. When diagnosed in stage I, up to 90% of patients can be cured with cytoreductive surgery and chemotherapy. Presently, only 25% of ovarian cancers are detected in stage I due, in part, to the absence of specific symptoms and to lack of an effective screening strategy or early ...
0 comments
Be the first person to recommend this.
It gives us great pleasure to announce the establishment of the NSW Regional Cancer Research Network. The NSW Regional Cancer Research Network has been established by NSW Regional Health Partners to build capacity in translational cancer research across the geographical area covered by the Central Coast, Hunter New England, Mid-North Coast and Northern NSW Local Health Districts. Over the next 4 years we will support and develop cancer research across these regions. The NSW Regional Cancer Research Network, with support from our project management team, will make the path to research impact more accessible for all cancer researchers in our regions. ...
0 comments

PhD Scholarships awarded

Be the first person to recommend this.
Congratulations to James Brown-Miles who has been awarded the first of the Cancer Research A non-invasive MRI-based quantification of nerves to identify dangerous tumours in prostate cancer and other human malignancies.
0 comments